These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38912304)

  • 1. Vascular endothelial growth factor is an effective biomarker for vascular dementia, not for Alzheimer's disease: A meta-analysis.
    Xu LZ; Li FY; Xu J; Li BQ; Li Y; Jia JP
    Alzheimers Dement (Amst); 2024; 16(2):e12612. PubMed ID: 38912304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular Endothelial Growth Factor remains unchanged in cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.
    Chakraborty A; Chatterjee M; Twaalfhoven H; Del Campo Milan M; Teunissen CE; Scheltens P; Fontijn RD; van Der Flier WM; de Vries HE
    Alzheimers Res Ther; 2018 Jun; 10(1):58. PubMed ID: 29933741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Vascular Endothelial Growth Factor Levels with Risk of Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Zakariaee SS; Naderi N; Azizi E
    J Prev Alzheimers Dis; 2024; 11(3):721-729. PubMed ID: 38706288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cerebrospinal fluid phosphorylated tau
    Kiđemet-Piskač S; Babić Leko M; Blažeković A; Langer Horvat L; Klepac N; Sonicki Z; Kolenc D; Hof PR; Boban M; Mimica N; Borovečki F; Šimić G
    CNS Neurosci Ther; 2018 Aug; 24(8):734-740. PubMed ID: 29453935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia.
    Tarkowski E; Issa R; Sjögren M; Wallin A; Blennow K; Tarkowski A; Kumar P
    Neurobiol Aging; 2002; 23(2):237-43. PubMed ID: 11804709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased release of the angiogenic peptide vascular endothelial growth factor in Alzheimer's disease: recovering effect with insulin and DHEA sulfate.
    Solerte SB; Ferrari E; Cuzzoni G; Locatelli E; Giustina A; Zamboni M; Schifino N; Rondanelli M; Gazzaruso C; Fioravanti M
    Dement Geriatr Cogn Disord; 2005; 19(1):1-10. PubMed ID: 15383738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid τ protein in differential diagnosis of Alzheimer's disease and vascular dementia in Chinese population: a meta-analysis.
    Liu B; Tang Y; Shen Y; Cen L; Han M
    Am J Alzheimers Dis Other Demen; 2014 Mar; 29(2):116-22. PubMed ID: 24164930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia.
    Llorens F; Schmitz M; Knipper T; Schmidt C; Lange P; Fischer A; Hermann P; Zerr I
    Front Aging Neurosci; 2017; 9():289. PubMed ID: 28955218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased serum angiogenin level in Alzheimer's disease.
    Kim YN; Kim DH
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):116-20. PubMed ID: 22449478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer's Disease.
    Minta K; Brinkmalm G; Portelius E; Johansson P; Svensson J; Kettunen P; Wallin A; Zetterberg H; Blennow K; Andreasson U
    J Alzheimers Dis; 2021; 79(2):729-741. PubMed ID: 33337373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of blood-brain barrier-related blood-borne factors for Alzheimer's disease vs. vascular dementia diagnosis: A pilot study.
    Gong M; Jia J
    Front Neurosci; 2022; 16():949129. PubMed ID: 36003963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodegeneration and Glial Activation Related CSF Biomarker as the Diagnosis of Alzheimer's Disease: A Systematic Review and an Updated Meta- analysis.
    Hao Y; Liu X; Zhu R
    Curr Alzheimer Res; 2022; 19(1):32-46. PubMed ID: 34879804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of inflammatory and hemostatic biomarkers in Alzheimer's and vascular dementia - A pilot study from a tertiary center in Northern India.
    Vishnu VY; Modi M; Garg VK; Mohanty M; Goyal MK; Lal V; Mittal BR; Prabhakar S
    Asian J Psychiatr; 2017 Oct; 29():59-62. PubMed ID: 29061429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia.
    Spies PE; Slats D; Sjögren JM; Kremer BP; Verhey FR; Rikkert MG; Verbeek MM
    Curr Alzheimer Res; 2010 Aug; 7(5):470-6. PubMed ID: 20043812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid levels of heart fatty acid binding protein are elevated prodromally in Alzheimer's disease and vascular dementia.
    Olsson B; Hertze J; Ohlsson M; Nägga K; Höglund K; Basun H; Annas P; Lannfelt L; Andreasen N; Minthon L; Zetterberg H; Blennow K; Hansson O
    J Alzheimers Dis; 2013; 34(3):673-9. PubMed ID: 23254629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis.
    Custodero C; Ciavarella A; Panza F; Gnocchi D; Lenato GM; Lee J; Mazzocca A; Sabbà C; Solfrizzi V
    Geroscience; 2022 Jun; 44(3):1373-1392. PubMed ID: 35486344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
    Hohman TJ; Bell SP; Jefferson AL;
    JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between lipocalin-2 and mild cognitive impairment or dementia: A systematic review and meta-analysis of population-based evidence.
    Li X; Wang X; Guo L; Wu K; Wang L; Rao L; Liu X; Kang C; Jiang B; Li Q; Li H; He F; Lu C
    Ageing Res Rev; 2023 Aug; 89():101984. PubMed ID: 37330019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer's disease.
    Guo LH; Alexopoulos P; Perneczky R
    Eur Arch Psychiatry Clin Neurosci; 2013 Oct; 263(7):553-60. PubMed ID: 23591828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of microRNA-210 in the cerebrospinal fluid and serum: Implications for Alzheimer's disease.
    Zhu Y; Li C; Sun A; Wang Y; Zhou S
    Exp Ther Med; 2015 Mar; 9(3):1013-1017. PubMed ID: 25667669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.